# Jiushi Shenkang

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiushi-shenkang

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.jssk-medical.com
- Total disclosed funding: $14M
- Latest round: Series A (Jun 3, 2020)
- Investors on record: 1

## About

Founded in 2016 and based in Beijing, China, Jiuzhi Shenkang operates as a medical company that focuses on the development and production of neuro-interventional medical devices. It has nearly 5,300 square meters of R&D and production base. The company established a quality management system of ISO13485 standards, with more than 30 patents. In June 2020, Jiushi Shenkang raised approximately RMB 100 million in series A funding led by new investor Apricot Capital.

Jiuzhi Shenkang is committed to providing total solutions for stroke prevention and treatment, and its main products are thrombus extraction products devices, including thrombus extraction stents, thrombus suction catheters, etc. It also has a product line of revolutionary products for the treatment of intracranial aneurysms, such as the blood flow guiding device.

The company generates revenue by selling neuro-interventional medical devices and related products.

## Funding rounds

- Series A, Jun 3, 2020, $14M — Apricot Capital

## Investors

- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A